Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPECITABINE vs CAPLACIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPECITABINE vs CAPLACIZUMAB: Safety Overview

Metric CAPECITABINE CAPLACIZUMAB
Total FAERS Reports 63,506 145
Deaths Reported 8,892 34
Death Rate 14.0% 23.4%
Hospitalizations 17,529 53
Average Patient Age 61.8 yrs 53.0 yrs
% Female Patients 65.1% 51.2%
FDA Approval Date Apr 17, 2018 N/A
Manufacturer Aurobindo Pharma Limited Genzyme Corporation
Route ORAL N/A
Marketing Status Discontinued N/A